Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-006403
Filing Date
2021-02-12
Accepted
2021-02-12 20:17:53
Documents
1
Period of Report
2021-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3939
  Complete submission text file 0000899243-21-006403.txt   5589
Mailing Address C/O 3200 WALNUT ST BOULDER CO 80301
Business Address
Robbins Andrew R (Reporting) CIK: 0001590157 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38443 | Film No.: 21631335

Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Issuer) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations